---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000532"
form_type: "8-K"
ticker: "SRRK"
cik: "0001727196"
company_name: "Scholar Rock Holding Corp"
filed_at: "2023-04-10T23:59:59+00:00"
generated_at: "2026-06-17T04:13:43.713561+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Scholar Rock appoints Richard Brudnick to Board of Directors

## Summary
- Richard Brudnick appointed to Board as independent director effective April 6, 2023.
- Board size increased to ten; Brudnick joins Audit Committee; Kristina Burow steps off.
- Brudnick is Chief Business Officer of Prime Medicine; previously at Bioverativ and Biogen.
- Srinivas Akkaraju appointed to Science, Innovation and Technology Committee.

## SEC filing metadata
- accession: 0001157523-23-000532
- form_type: 8-K
- ticker: SRRK
- cik: 0001727196
- company_name: Scholar Rock Holding Corp
- filed_at: 2023-04-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/0001157523-23-000532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/a53377626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000532
- JSON: https://secwatch.observer/filing/0001157523-23-000532.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000532.txt

## Key facts
- Executive change
  Richard Brudnick was appointed as Director at Scholar Rock Holding Corp.
  - Action: appointed
  - Role: Director
  source text: appointed Richard Brudnick to join the Board, effective on April 6, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/0001157523-23-000532-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.